Thrombosis and coagulopathy in COVID-19: A current narrative-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thrombosis and coagulopathy in COVID-19: A current narrative

Published:2024 Issue: Volume: Page:337-348
ISSN:
Container-title:Management, Body Systems, and Case Studies in COVID-19
language:en
Short-container-title:

Author:

Lazo-Langner Alejandro^ORCID,Porres-Aguilar Mateo^ORCID

Publisher

Elsevier

Reference64 articles.

1. COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection;Al-Samkari;Blood,2020

2. Randomized study of rivaroxaban vs placebo on disease progression and symptoms resolution in high-risk adults with mild coronavirus disease 2019;Ananworanich;Clinical Infectious Diseases,2022

3. COVID-19-associated coagulopathy and disseminated intravascular coagulation;Asakura;International Journal of Hematology,2021

4. Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION randomized trial;Bikdeli;Thrombosis and Haemostasis,2022

5. Pathophysiology of SARS-CoV-2: The Mount Sinai COVID-19 autopsy experience;Bryce;Modern Pathology,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3